Growth Metrics

Nexalin Technology (NXL) Receivables - Net (2021 - 2026)

Nexalin Technology's quarterly Receivables - Net came in at $43004.0 in Q1 2026, up 197.01% year-on-year from $14479.0 in Q1 2025, and down 47.28% quarter-over-quarter from $81571.0 in Q4 2025.

Nexalin Technology has reported Receivables - Net for 6 years, with the latest figure at $43004.0 in Q1 2026.

  • For the quarter ending Q1 2026, Receivables - Net rose 197.01% year-over-year to $43004.0; the trailing twelve-month figure through Mar 2026 stood at $43004.0 (up 197.01% YoY), and the FY2025 full-year result was $81571.0, up 525.4% from the prior year.
  • Receivables - Net for Q1 2026 stood at $43004.0, down from $81571.0 in the prior quarter.
  • The five-year high for Receivables - Net was $81571.0 in Q4 2025, with the low at $3550.0 in Q1 2023.
  • Average Receivables - Net over 5 years is $20491.4, with a median of $13043.0 recorded in 2024.
  • Year-over-year, Receivables - Net tumbled 70.1% in 2022 and surged 525.4% in 2025.
  • Tracing NXL's Receivables - Net over 5 years: stood at $4875.0 in 2022, then soared by 92.18% to $9369.0 in 2023, then soared by 39.21% to $13043.0 in 2024, then surged by 525.4% to $81571.0 in 2025, then slumped by 47.28% to $43004.0 in 2026.
  • The last three Receivables - Net figures came in at $43004.0 (Q1 2026), $81571.0 (Q4 2025), and $7925.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 43,004.00
Mar 31, 2026 43,004.00
Dec 31, 2025 81,571.00
Dec 31, 2025 81,571.00
Sep 30, 2025 7,925.00
Sep 30, 2025 7,925.00
Jun 30, 2025 59,841.00
Jun 30, 2025 59,841.00
Mar 31, 2025 14,479.00
Mar 31, 2025 14,479.00
Dec 31, 2024 13,043.00
Dec 31, 2024 13,043.00
Sep 30, 2024 15,171.00
Sep 30, 2024 15,171.00
Jun 30, 2024 11,720.00
Jun 30, 2024 11,720.00
Mar 31, 2024 3,666.00
Mar 31, 2024 3,666.00
Dec 31, 2023 9,369.00
Dec 31, 2023 9,369.00
Sep 30, 2023 14,483.00
Sep 30, 2023 14,483.00
Jun 30, 2023 14,322.00
Jun 30, 2023 14,322.00
Mar 31, 2023 3,550.00
Mar 31, 2023 3,550.00
Dec 31, 2022 4,875.00
Dec 31, 2022 4,875.00
Sep 30, 2022 10,352.00
Sep 30, 2022 10,352.00
Dec 31, 2021 16,303.00
Dec 31, 2021 16,303.00